Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Brudno, J. N., Lam, N., Vanasse, D., Shen, Y., Rose, J. J., Rossi, J., Xue, A., Bot, A., Scholler, N., Mikkilineni, L., Roschewski, M., Dean, R., Cachau, R., Youkharibache, P., Patel, R., Hansen, B., Stroncek, D. F., Rosenberg, S. A., Gress, R. E., Kochenderfer, J. N.  Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.  Nature Medicine.  (2020).  doi: 10.1038/s41591-019-0737-3